A detailed history of Black Rock Inc. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 6,015,711 shares of EWTX stock, worth $192 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,015,711
Previous 5,167,006 16.43%
Holding current value
$192 Million
Previous $94.2 Million 14.96%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$15.08 - $21.23 $12.8 Million - $18 Million
848,705 Added 16.43%
6,015,711 $108 Million
Q1 2024

May 10, 2024

BUY
$9.25 - $19.97 $17.2 Million - $37.1 Million
1,859,896 Added 56.24%
5,167,006 $94.2 Million
Q4 2023

Feb 13, 2024

BUY
$5.51 - $12.1 $1.77 Million - $3.89 Million
321,266 Added 10.76%
3,307,110 $36.2 Million
Q3 2023

Nov 13, 2023

SELL
$5.73 - $7.69 $849,896 - $1.14 Million
-148,324 Reduced 4.73%
2,985,844 $17.1 Million
Q2 2023

Aug 11, 2023

BUY
$5.71 - $10.29 $1.5 Million - $2.71 Million
263,161 Added 9.17%
3,134,168 $24.3 Million
Q1 2023

May 12, 2023

SELL
$6.66 - $11.33 $17,429 - $29,650
-2,617 Reduced 0.09%
2,871,007 $19.1 Million
Q4 2022

Feb 13, 2023

BUY
$7.58 - $11.08 $5.75 Million - $8.4 Million
758,154 Added 35.84%
2,873,624 $25.7 Million
Q3 2022

Nov 14, 2022

BUY
$8.08 - $13.58 $500,168 - $840,629
61,902 Added 3.01%
2,115,470 $20.8 Million
Q2 2022

Aug 12, 2022

SELL
$5.67 - $9.87 $9,026 - $15,713
-1,592 Reduced 0.08%
2,053,568 $16.3 Million
Q1 2022

May 12, 2022

BUY
$9.1 - $18.97 $68,768 - $143,356
7,557 Added 0.37%
2,055,160 $19.9 Million
Q4 2021

Feb 10, 2022

BUY
$14.41 - $22.41 $21.1 Million - $32.9 Million
1,467,371 Added 252.89%
2,047,603 $31.3 Million
Q3 2021

Nov 09, 2021

BUY
$14.11 - $24.1 $180,241 - $307,853
12,774 Added 2.25%
580,232 $9.63 Million
Q2 2021

Aug 11, 2021

BUY
$21.33 - $30.25 $12.1 Million - $17.2 Million
567,458 New
567,458 $12.1 Million

Others Institutions Holding EWTX

About Edgewise Therapeutics, Inc.


  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $2.02B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.